What is Benign Prostatic Hyperplasia (BPH)?

MDS Prognosis - Understanding IPSS and IPSS-R Scores 2018

Benefits and drawbacks of the IPSS-M

6-Molecular prognostic scoring (IPSS-M) – How does it improve patient management?

What is the difference between the IPSS and the IPSS-R?

#684 COMPARISON OF IPSS AND ICIQ MLUTS SCORES IN MEN WITH VOIDING LOWER URINARY TRACT SYMPTOMS

#381 PREDICTIVE VALUE OF INTERNATIONAL PROSTATE SYMPTOM SCORE ITEMS ON ALTERATION IN LOWER URINA...

Relevance of IPSS-R for risk stratification in patients with MDS who undergo SCT

Effects of Exercise on Benign Prostatic Hyperplasia

Feasibility of the IPSS-M in CMML

S2E3: IPSS and Pressure Flow Studies: Inaccurate predictor of BPH BPO ?!

Myelofibrosis Prognostic Scoring Systems: IPSS, DIPSS, DIPSS-Plus, MISPS, and GIPSS

VMMC Campbell Lecture Series: BPH

Prostate Artery Embolization

BPH Management in Elderly Patients - EMPIRE Urology Lecture Series

IPSS Webinar: Is this Simulation Based Medical Education Study Valid? (Part 1) By Martin Pusic

Current Evidence in the Medical Management of Benign Prostatic Hyperplasia

Treating BPH: Comparing HoLEP, Rezūm, UroLift, and Aquablation

PAE: A Primer for Urologists

Oxford University surgical lectures: prostate artery embolisation in the management of BPH